Related Experiment Video

Updated: May 13, 2026

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa
07:27

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Published on: July 12, 2018

Type III secretion of ExoU is critical during early Pseudomonas aeruginosa pneumonia

Heather A Howell1, Latania K Logan, Alan R Hauser

  • 1Department of Microbiology/Immunology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.

Mbio
|March 14, 2013
PubMed
Abstract

Insights

Early expression of the Pseudomonas aeruginosa exoU gene is critical for bacterial survival during pneumonia. Delays in ExoU secretion significantly reduced bacterial burden and improved survival in mouse models.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Bacterial Pathogenesis

Background:

  • Pseudomonas aeruginosa is a significant cause of healthcare-associated infections, especially in immunocompromised patients.
  • The type III secretion system (T3SS) is a key virulence factor, injecting toxins like ExoU into host cells.
  • ExoU is a highly cytotoxic effector protein causing rapid host cell death.

Purpose of the Study:

  • To investigate the timing of type III effector ExoU secretion during acute Pseudomonas aeruginosa pneumonia in a mammalian model.
  • To determine the impact of early ExoU expression on bacterial survival and host outcomes.

Main Methods:

  • Utilized a mouse model of acute P. aeruginosa pneumonia.
  • Employed immunofluorescence microscopy to track ExoU protein levels in the lung over time.
  • Generated a P. aeruginosa strain with inducible ExoU production to control secretion timing.

Main Results:

  • The exoU gene was induced and ExoU protein was produced early during acute pneumonia.
  • Increased ExoU protein levels were observed in the lung over the course of infection.
  • A delay in ExoU expression by as little as 3 hours led to reduced bacterial burdens and improved survival in mice.

Conclusions:

  • Early expression of exoU is critical for P. aeruginosa survival and virulence during pneumonia.
  • Therapeutic strategies targeting the timing of ExoU secretion may be effective.
  • Understanding virulence factor regulation is crucial for developing novel anti-infective therapies.

More Related Videos

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives10:26

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives

Published on: June 15, 2020

Pseudomonas aeruginosa Induced Lung Injury Model07:24

Pseudomonas aeruginosa Induced Lung Injury Model

Published on: October 29, 2014

Related Concept Videos

Gram-negative Bacterial Protein Secretion Systems01:17

Gram-negative Bacterial Protein Secretion Systems

Gram-negative bacteria utilize sophisticated protein secretion systems to transport proteins across their double-membrane envelope into the extracellular environment or host cells. Based on their mechanism of action, these systems are classified into one-step and two-step pathways.One-Step Secretion Systems (Types I, III, IV, and VI)One-step secretion systems bypass the periplasm entirely, forming a continuous channel that spans both the inner and outer membranes:Type I Secretion System (T1SS):...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...